graphpad prism v.10.1.0 Search Results


95
Bioss interferon beta elisa kit bioss antibodies bskh6018496t truecount bd 663028 software flowjo v10 10
Interferon Beta Elisa Kit Bioss Antibodies Bskh6018496t Truecount Bd 663028 Software Flowjo V10 10, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/interferon beta elisa kit bioss antibodies bskh6018496t truecount bd 663028 software flowjo v10 10/product/Bioss
Average 95 stars, based on 1 article reviews
interferon beta elisa kit bioss antibodies bskh6018496t truecount bd 663028 software flowjo v10 10 - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

90
GraphPad Software Inc prism v 10.1.0 program
Prism V 10.1.0 Program, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prism v 10.1.0 program/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prism v 10.1.0 program - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc graphpad prism v.10.1.0
Graphpad Prism V.10.1.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/graphpad prism v.10.1.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
graphpad prism v.10.1.0 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc prism 10
Prism 10, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prism 10/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prism 10 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc prism’s outlier calculator with grubbs’ test
Prism’s Outlier Calculator With Grubbs’ Test, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prism’s outlier calculator with grubbs’ test/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prism’s outlier calculator with grubbs’ test - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
SPSS Inc statistics version 29.0.1
Statistics Version 29.0.1, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/statistics version 29.0.1/product/SPSS Inc
Average 90 stars, based on 1 article reviews
statistics version 29.0.1 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Becton Dickinson v10.10
V10.10, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/v10.10/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
v10.10 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc boxplots and heatmap for aqua peptides analysis
Targeted proteomics by automated quantification proteomics approach further characterised ATA+(a) and ATA+(b) group (validation cohort). ( A ) Heatmap represents selected proteins expression among groups. ( B ) <t>Boxplots</t> represent detailed overexpressed proteins in ATA+(a) group both vs ATA+(b) and HC ( B ). NS: non-significant (p value>0.05); *p value<0.05; **p value<0.01; ***p value<0.001; ***p value<0.0001. ATA+, anti-topoisomerase-I positive patients (N=24); ATA+(a), ATA+group a (N=11); ATA+(b), ATA+group b (N=13); ACA+, anti-centromere positive patients (N=18); ARA+, anti-RNA polymerase-III positive patients (N=5); ATA+, anti-topoisomerase-I positive patients; ATA+ (a) , anti-topoisomerase-I positive patients group a; ATA+ (b) , anti-topoisomerase-I positive patients group b; CDH2, cadherin 2; CDH5, VE-cadherin; CISD1, CDGSH iron sulphur domain 1; EIF2B3, eukaryotic translation initiation factor 2B subunit gamma; EPS15, epidermal growth factor receptor pathway substrate 15; FKBP11, FKBP prolyl isomerase 11; HC, healthy controls (N=20); ICAM-1, intercellular adhesion molecule 1; ITGA3, integrin alpha-3; NRBP1, nuclear receptor-binding protein; P4HA2, prolyl 4-hydroxylase subunit alpha-2; PNN, desmosome associated protein; RAE1, Rae1 RNA export 1; SEL1L, adaptor subunit of SYVN1 ubiquitin ligase; SNRPA, small nuclear ribonucleoprotein polypeptide A; STAM, signal transducing adaptor molecule; STK24, serine/threonine-protein kinase 24; TPP1, tripeptidyl-peptidase 1; TTN, titin.
Boxplots And Heatmap For Aqua Peptides Analysis, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/boxplots and heatmap for aqua peptides analysis/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
boxplots and heatmap for aqua peptides analysis - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc agonist vs. response –variable slope analysis in graphpad prism software
Targeted proteomics by automated quantification proteomics approach further characterised ATA+(a) and ATA+(b) group (validation cohort). ( A ) Heatmap represents selected proteins expression among groups. ( B ) <t>Boxplots</t> represent detailed overexpressed proteins in ATA+(a) group both vs ATA+(b) and HC ( B ). NS: non-significant (p value>0.05); *p value<0.05; **p value<0.01; ***p value<0.001; ***p value<0.0001. ATA+, anti-topoisomerase-I positive patients (N=24); ATA+(a), ATA+group a (N=11); ATA+(b), ATA+group b (N=13); ACA+, anti-centromere positive patients (N=18); ARA+, anti-RNA polymerase-III positive patients (N=5); ATA+, anti-topoisomerase-I positive patients; ATA+ (a) , anti-topoisomerase-I positive patients group a; ATA+ (b) , anti-topoisomerase-I positive patients group b; CDH2, cadherin 2; CDH5, VE-cadherin; CISD1, CDGSH iron sulphur domain 1; EIF2B3, eukaryotic translation initiation factor 2B subunit gamma; EPS15, epidermal growth factor receptor pathway substrate 15; FKBP11, FKBP prolyl isomerase 11; HC, healthy controls (N=20); ICAM-1, intercellular adhesion molecule 1; ITGA3, integrin alpha-3; NRBP1, nuclear receptor-binding protein; P4HA2, prolyl 4-hydroxylase subunit alpha-2; PNN, desmosome associated protein; RAE1, Rae1 RNA export 1; SEL1L, adaptor subunit of SYVN1 ubiquitin ligase; SNRPA, small nuclear ribonucleoprotein polypeptide A; STAM, signal transducing adaptor molecule; STK24, serine/threonine-protein kinase 24; TPP1, tripeptidyl-peptidase 1; TTN, titin.
Agonist Vs. Response –Variable Slope Analysis In Graphpad Prism Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/agonist vs. response –variable slope analysis in graphpad prism software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
agonist vs. response –variable slope analysis in graphpad prism software - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc log [inhibitor] vs response (variable slope) curve graphpad prism 10.1.0
Targeted proteomics by automated quantification proteomics approach further characterised ATA+(a) and ATA+(b) group (validation cohort). ( A ) Heatmap represents selected proteins expression among groups. ( B ) <t>Boxplots</t> represent detailed overexpressed proteins in ATA+(a) group both vs ATA+(b) and HC ( B ). NS: non-significant (p value>0.05); *p value<0.05; **p value<0.01; ***p value<0.001; ***p value<0.0001. ATA+, anti-topoisomerase-I positive patients (N=24); ATA+(a), ATA+group a (N=11); ATA+(b), ATA+group b (N=13); ACA+, anti-centromere positive patients (N=18); ARA+, anti-RNA polymerase-III positive patients (N=5); ATA+, anti-topoisomerase-I positive patients; ATA+ (a) , anti-topoisomerase-I positive patients group a; ATA+ (b) , anti-topoisomerase-I positive patients group b; CDH2, cadherin 2; CDH5, VE-cadherin; CISD1, CDGSH iron sulphur domain 1; EIF2B3, eukaryotic translation initiation factor 2B subunit gamma; EPS15, epidermal growth factor receptor pathway substrate 15; FKBP11, FKBP prolyl isomerase 11; HC, healthy controls (N=20); ICAM-1, intercellular adhesion molecule 1; ITGA3, integrin alpha-3; NRBP1, nuclear receptor-binding protein; P4HA2, prolyl 4-hydroxylase subunit alpha-2; PNN, desmosome associated protein; RAE1, Rae1 RNA export 1; SEL1L, adaptor subunit of SYVN1 ubiquitin ligase; SNRPA, small nuclear ribonucleoprotein polypeptide A; STAM, signal transducing adaptor molecule; STK24, serine/threonine-protein kinase 24; TPP1, tripeptidyl-peptidase 1; TTN, titin.
Log [Inhibitor] Vs Response (Variable Slope) Curve Graphpad Prism 10.1.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/log [inhibitor] vs response (variable slope) curve graphpad prism 10.1.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
log [inhibitor] vs response (variable slope) curve graphpad prism 10.1.0 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc straight-line least squares regression
Targeted proteomics by automated quantification proteomics approach further characterised ATA+(a) and ATA+(b) group (validation cohort). ( A ) Heatmap represents selected proteins expression among groups. ( B ) <t>Boxplots</t> represent detailed overexpressed proteins in ATA+(a) group both vs ATA+(b) and HC ( B ). NS: non-significant (p value>0.05); *p value<0.05; **p value<0.01; ***p value<0.001; ***p value<0.0001. ATA+, anti-topoisomerase-I positive patients (N=24); ATA+(a), ATA+group a (N=11); ATA+(b), ATA+group b (N=13); ACA+, anti-centromere positive patients (N=18); ARA+, anti-RNA polymerase-III positive patients (N=5); ATA+, anti-topoisomerase-I positive patients; ATA+ (a) , anti-topoisomerase-I positive patients group a; ATA+ (b) , anti-topoisomerase-I positive patients group b; CDH2, cadherin 2; CDH5, VE-cadherin; CISD1, CDGSH iron sulphur domain 1; EIF2B3, eukaryotic translation initiation factor 2B subunit gamma; EPS15, epidermal growth factor receptor pathway substrate 15; FKBP11, FKBP prolyl isomerase 11; HC, healthy controls (N=20); ICAM-1, intercellular adhesion molecule 1; ITGA3, integrin alpha-3; NRBP1, nuclear receptor-binding protein; P4HA2, prolyl 4-hydroxylase subunit alpha-2; PNN, desmosome associated protein; RAE1, Rae1 RNA export 1; SEL1L, adaptor subunit of SYVN1 ubiquitin ligase; SNRPA, small nuclear ribonucleoprotein polypeptide A; STAM, signal transducing adaptor molecule; STK24, serine/threonine-protein kinase 24; TPP1, tripeptidyl-peptidase 1; TTN, titin.
Straight Line Least Squares Regression, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/straight-line least squares regression/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
straight-line least squares regression - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
TIBCO software v. 13.0
Targeted proteomics by automated quantification proteomics approach further characterised ATA+(a) and ATA+(b) group (validation cohort). ( A ) Heatmap represents selected proteins expression among groups. ( B ) <t>Boxplots</t> represent detailed overexpressed proteins in ATA+(a) group both vs ATA+(b) and HC ( B ). NS: non-significant (p value>0.05); *p value<0.05; **p value<0.01; ***p value<0.001; ***p value<0.0001. ATA+, anti-topoisomerase-I positive patients (N=24); ATA+(a), ATA+group a (N=11); ATA+(b), ATA+group b (N=13); ACA+, anti-centromere positive patients (N=18); ARA+, anti-RNA polymerase-III positive patients (N=5); ATA+, anti-topoisomerase-I positive patients; ATA+ (a) , anti-topoisomerase-I positive patients group a; ATA+ (b) , anti-topoisomerase-I positive patients group b; CDH2, cadherin 2; CDH5, VE-cadherin; CISD1, CDGSH iron sulphur domain 1; EIF2B3, eukaryotic translation initiation factor 2B subunit gamma; EPS15, epidermal growth factor receptor pathway substrate 15; FKBP11, FKBP prolyl isomerase 11; HC, healthy controls (N=20); ICAM-1, intercellular adhesion molecule 1; ITGA3, integrin alpha-3; NRBP1, nuclear receptor-binding protein; P4HA2, prolyl 4-hydroxylase subunit alpha-2; PNN, desmosome associated protein; RAE1, Rae1 RNA export 1; SEL1L, adaptor subunit of SYVN1 ubiquitin ligase; SNRPA, small nuclear ribonucleoprotein polypeptide A; STAM, signal transducing adaptor molecule; STK24, serine/threonine-protein kinase 24; TPP1, tripeptidyl-peptidase 1; TTN, titin.
Software V. 13.0, supplied by TIBCO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/software v. 13.0/product/TIBCO
Average 90 stars, based on 1 article reviews
software v. 13.0 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Targeted proteomics by automated quantification proteomics approach further characterised ATA+(a) and ATA+(b) group (validation cohort). ( A ) Heatmap represents selected proteins expression among groups. ( B ) Boxplots represent detailed overexpressed proteins in ATA+(a) group both vs ATA+(b) and HC ( B ). NS: non-significant (p value>0.05); *p value<0.05; **p value<0.01; ***p value<0.001; ***p value<0.0001. ATA+, anti-topoisomerase-I positive patients (N=24); ATA+(a), ATA+group a (N=11); ATA+(b), ATA+group b (N=13); ACA+, anti-centromere positive patients (N=18); ARA+, anti-RNA polymerase-III positive patients (N=5); ATA+, anti-topoisomerase-I positive patients; ATA+ (a) , anti-topoisomerase-I positive patients group a; ATA+ (b) , anti-topoisomerase-I positive patients group b; CDH2, cadherin 2; CDH5, VE-cadherin; CISD1, CDGSH iron sulphur domain 1; EIF2B3, eukaryotic translation initiation factor 2B subunit gamma; EPS15, epidermal growth factor receptor pathway substrate 15; FKBP11, FKBP prolyl isomerase 11; HC, healthy controls (N=20); ICAM-1, intercellular adhesion molecule 1; ITGA3, integrin alpha-3; NRBP1, nuclear receptor-binding protein; P4HA2, prolyl 4-hydroxylase subunit alpha-2; PNN, desmosome associated protein; RAE1, Rae1 RNA export 1; SEL1L, adaptor subunit of SYVN1 ubiquitin ligase; SNRPA, small nuclear ribonucleoprotein polypeptide A; STAM, signal transducing adaptor molecule; STK24, serine/threonine-protein kinase 24; TPP1, tripeptidyl-peptidase 1; TTN, titin.

Journal: RMD Open

Article Title: Immunoglobulins G from Patients with Systemic Sclerosis Modify the Molecular Signatures of Endothelial Cells

doi: 10.1136/rmdopen-2024-004290

Figure Lengend Snippet: Targeted proteomics by automated quantification proteomics approach further characterised ATA+(a) and ATA+(b) group (validation cohort). ( A ) Heatmap represents selected proteins expression among groups. ( B ) Boxplots represent detailed overexpressed proteins in ATA+(a) group both vs ATA+(b) and HC ( B ). NS: non-significant (p value>0.05); *p value<0.05; **p value<0.01; ***p value<0.001; ***p value<0.0001. ATA+, anti-topoisomerase-I positive patients (N=24); ATA+(a), ATA+group a (N=11); ATA+(b), ATA+group b (N=13); ACA+, anti-centromere positive patients (N=18); ARA+, anti-RNA polymerase-III positive patients (N=5); ATA+, anti-topoisomerase-I positive patients; ATA+ (a) , anti-topoisomerase-I positive patients group a; ATA+ (b) , anti-topoisomerase-I positive patients group b; CDH2, cadherin 2; CDH5, VE-cadherin; CISD1, CDGSH iron sulphur domain 1; EIF2B3, eukaryotic translation initiation factor 2B subunit gamma; EPS15, epidermal growth factor receptor pathway substrate 15; FKBP11, FKBP prolyl isomerase 11; HC, healthy controls (N=20); ICAM-1, intercellular adhesion molecule 1; ITGA3, integrin alpha-3; NRBP1, nuclear receptor-binding protein; P4HA2, prolyl 4-hydroxylase subunit alpha-2; PNN, desmosome associated protein; RAE1, Rae1 RNA export 1; SEL1L, adaptor subunit of SYVN1 ubiquitin ligase; SNRPA, small nuclear ribonucleoprotein polypeptide A; STAM, signal transducing adaptor molecule; STK24, serine/threonine-protein kinase 24; TPP1, tripeptidyl-peptidase 1; TTN, titin.

Article Snippet: Boxplots and heatmap for AQUA peptides analysis were performed with GraphPad Prism (V.10.1.0, San Diego, California, USA).

Techniques: Targeted Proteomics, Biomarker Discovery, Expressing, Binding Assay, Ubiquitin Proteomics